CRNX Crinetics Pharmaceuticals, Inc.
Fundamentals / CIK 0001658247 / USDCrinetics Pharmaceuticals, Inc. reported $42.16M in revenue and a net loss of $501.6M for the trailing twelve months ended June 30, 2026 (up 2336.3% year over year), with a 15.7% gross margin and a -1302.5% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CRNX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$42.16M +2336.3% YoY
-
Operating Income TTM-$549.1M -1302.5% margin
-
Net Income TTM-$501.6M -1189.9% net margin
-
Diluted EPS TTM-$4.75 Split-adjusted
-
Free Cash Flow TTM-$425.2M -1008.6% FCF margin
-
Cash & ST Investments Jun 30, 2026$1.21B Total debt: $47.19M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.70M | $1.04M | $4.01M | $4.74M | $1.08M | $71K | $1.19M | $2.43M | $2.04M | $589K |
| Cost of Revenue | $1.08M | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | $6.62M | $1.04M | $4.01M | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $332.1M | $240.2M | $168.5M | $130.2M | $84.25M | $57.00M | $41.51M | $24.48M | $9.23M | $5.10M |
| Selling, General & Admin | $191.3M | $99.74M | $58.09M | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | $339.9M | $226.6M | $172.6M | $108.8M | $75.02M | $55.02M | $31.14M | $11.17M | $6.63M |
| Operating Income | -$516.8M | -$338.9M | -$222.6M | -$167.9M | -$107.7M | -$74.95M | -$53.83M | -$28.71M | -$9.13M | -$6.04M |
| EBITDA | -$512.9M | -$336.1M | -$221.5M | -$166.9M | -$106.8M | -$74.00M | -$52.95M | -$28.24M | -$9.00M | -$5.95M |
| Interest Income | $51.99M | $41.44M | $13.44M | $4.32M | $157K | $991K | $3.46M | $1.75M | $26K | $37K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $8.0K | $11K |
| Income Before Tax | -$465.1M | -$298.4M | -$214.5M | -$163.9M | -$107.6M | -$73.81M | -$50.42M | -$27.11M | -$9.16M | -$6.02M |
| Income Tax Expense | $180K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$465.3M | -$298.4M | -$214.5M | -$163.9M | -$107.6M | -$73.81M | -$50.42M | -$27.11M | -$9.16M | -$6.02M |
| Basic EPS | -$4.95 | -$3.69 | -$3.69 | -$3.15 | -$2.80 | -$2.42 | -$2.09 | -$2.23 | -$6.68 | -$5.96 |
| Diluted EPS | -$4.95 | -$3.69 | -$3.69 | -$3.15 | -$2.80 | -$2.42 | -$2.09 | -$2.23 | -$6.68 | -$5.96 |
| Basic Shares Outstanding | 94.1M | 80.8M | 58.1M | 52.0M | 38.4M | 30.4M | 24.2M | 12.1M | 1.4M | 1.0M |
| Diluted Shares Outstanding | 94.1M | 80.8M | 58.1M | 52.0M | 38.4M | 30.4M | 24.2M | 12.1M | 1.4M | 1.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.12M | $10.73M | $6.16M | $143K | $1.03M | $361K | $0 | $0 |
| Cost of Revenue | $154K | $200K | -- | -- | $0 | $0 | -- | -- |
| Gross Profit | $24.96M | $10.53M | -- | -- | $1.03M | $361K | -- | -- |
| Research & Development | $99.85M | $100.1M | $85.05M | $90.46M | $80.30M | $76.24M | $66.57M | $61.91M |
| Selling, General & Admin | -- | -- | -- | -- | $49.84M | $35.53M | -- | -- |
| Total Operating Expenses | -- | -- | -- | $142.7M | $130.1M | $111.8M | $94.75M | $87.80M |
| Operating Income | -$132.5M | -$140.4M | -$133.7M | -$142.6M | -$129.1M | -$111.4M | -$94.75M | -$87.80M |
| EBITDA | -$131.4M | -$139.2M | -$132.7M | -$141.6M | -$128.2M | -$110.5M | -$93.96M | -$87.03M |
| Interest Income | $12.03M | $12.66M | $11.16M | $12.54M | $13.46M | $14.83M | $14.37M | $11.01M |
| Income Before Tax | -- | -- | -- | -$130.1M | -- | -- | -- | -$76.83M |
| Net Income | -$120.9M | -$127.8M | -$122.8M | -$130.1M | -$115.6M | -$96.77M | -$80.59M | -$76.83M |
| Basic EPS | -$1.14 | -$1.23 | -- | -$1.38 | -$1.23 | -$1.04 | -- | -$0.96 |
| Diluted EPS | -$1.14 | -$1.23 | -- | -$1.38 | -$1.23 | -$1.04 | -- | -$0.96 |
| Basic Shares Outstanding | 105.6M | 104.1M | -- | 94.2M | 93.8M | 93.1M | -- | 80.1M |
| Diluted Shares Outstanding | 105.6M | 104.1M | -- | 94.2M | 93.8M | 93.1M | -- | 80.1M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $101.5M | $264.5M | $54.90M | $32.67M | $200.7M | $93.09M | $40.33M | $44.97M | $14.19M |
| Short-Term Investments | $926.4M | $1.09B | $503.7M | $301.8M | $133.0M | $77.79M | $78.07M | $118.9M | -- |
| Cash & Short-Term Investments | $1.00B | $1.40B | $558.6M | $334.4M | $333.7M | $170.9M | $118.4M | $163.9M | $14.19M |
| Accounts Receivable, Net | $592K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $2.02M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $3.46M | $2.39M | $448K | $1.93M | $912K | $1.02M | $668K | $876K | $239K |
| Total Current Assets | $1.05B | $1.38B | $574.2M | $345.2M | $344.7M | $177.5M | $123.3M | $166.7M | $15.16M |
| Property, Plant & Equipment, Net | $14.30M | $12.07M | $10.88M | $3.50M | $2.83M | $3.18M | $3.95M | $4.23M | $400K |
| Other Non-Current Assets | -- | $2.83M | $2.00M | $37K | $0 | $40K | $82K | -- | $33K |
| Total Non-Current Assets | $77.92M | $59.20M | $61.20M | $6.99M | $6.29M | $5.95M | $7.04M | $4.73M | $433K |
| Total Assets | $1.13B | $1.43B | $635.4M | $352.2M | $351.0M | $183.4M | $130.4M | $171.4M | $15.60M |
| Accounts Payable | $22.61M | $5.85M | $6.55M | $6.88M | $3.42M | -- | -- | $1.46M | $403K |
| Deferred Revenue (Current) | $1.24M | $2.18M | $2.06M | $2.20M | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | $1.05M | $939K | $835K | $724K | $381K | -- |
| Total Current Liabilities | $85.07M | $59.68M | $43.94M | $27.72M | $15.99M | $10.49M | $8.34M | $7.92M | $897K |
| Deferred Revenue (Non-Current) | $3.81M | $4.70M | $4.75M | $6.10M | $0 | -- | -- | -- | -- |
| Other Non-Current Liabilities | $3.24M | $829K | $0 | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $49.10M | $50.10M | $52.30M | $8.12M | $3.08M | $4.04M | $4.90M | $3.27M | $23K |
| Total Liabilities | $134.2M | $109.8M | $96.25M | $35.85M | $19.07M | $14.53M | $13.24M | $11.19M | $920K |
| Total Debt (incl. Leases) | $48.54M | $51.72M | $51.73M | $3.08M | $4.01M | $4.85M | $5.57M | -- | -- |
| Common Stock | $2.41B | $2.28B | $253K | $0 | $607.6M | $336.5M | $210.8M | $24K | $1.0K |
| Retained Earnings | -$1.42B | -$952.1M | -$653.7M | -$439.2M | -$275.3M | -$167.6M | -$93.80M | -$43.38M | -$16.27M |
| Accumulated Other Comp. Income | $1.86M | $963K | $977K | -$3.93M | -$382K | $25K | $148K | $61K | -- |
| Total Stockholders' Equity | $992.1M | $1.32B | $539.1M | $316.3M | $331.9M | $168.9M | $117.1M | $160.2M | -$15.02M |
| Total Equity | $992.1M | $1.32B | $539.1M | $316.3M | $331.9M | $168.9M | $117.1M | $160.2M | -$15.02M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $55.50M | $114.3M | $101.5M | $110.9M | $53.73M | $94.57M | $264.5M | $317.3M |
| Short-Term Investments | $1.15B | $1.18B | $926.4M | $981.4M | $1.14B | $1.18B | $1.09B | $545.4M |
| Cash & Short-Term Investments | $1.20B | $1.30B | $1.00B | $1.10B | $1.20B | $1.30B | $1.40B | $862.7M |
| Accounts Receivable, Net | $11.96M | $5.68M | $592K | -- | -- | -- | $0 | -- |
| Inventory | $3.49M | $3.06M | $2.02M | -- | -- | -- | $0 | -- |
| Other Current Assets | $4.71M | $6.43M | $3.46M | $4.81M | $3.69M | $2.70M | $2.39M | $1.49M |
| Total Current Assets | $1.24B | $1.32B | $1.05B | $1.12B | $1.22B | $1.29B | $1.38B | $877.6M |
| Property, Plant & Equipment, Net | $13.07M | $13.50M | $14.30M | $14.38M | $14.67M | $12.63M | $12.07M | $11.71M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | $14.15M | $2.83M | $2.51M |
| Total Non-Current Assets | $77.52M | $78.91M | $77.92M | $74.76M | $72.31M | $70.27M | $59.20M | $59.79M |
| Total Assets | $1.32B | $1.40B | $1.13B | $1.20B | $1.29B | $1.36B | $1.43B | $937.4M |
| Accounts Payable | $13.25M | $12.88M | $22.61M | $6.11M | $11.32M | $9.84M | $5.85M | $4.94M |
| Deferred Revenue (Current) | $1.67M | $1.27M | $1.24M | -- | -- | -- | $2.18M | $1.69M |
| Total Current Liabilities | $79.92M | $71.09M | $85.07M | $74.16M | $68.40M | $57.31M | $59.68M | $53.56M |
| Deferred Revenue (Non-Current) | $3.46M | $3.35M | $3.81M | $4.11M | $3.99M | $4.31M | $4.70M | $5.20M |
| Other Non-Current Liabilities | $5.93M | $4.93M | $3.24M | $2.89M | $2.33M | $1.77M | $829K | $511K |
| Total Non-Current Liabilities | $50.01M | $49.59M | $49.10M | $49.71M | $49.65M | $50.02M | $50.10M | $50.83M |
| Total Liabilities | $129.9M | $120.7M | $134.2M | $123.9M | $118.0M | $107.3M | $109.8M | $104.4M |
| Total Debt (incl. Leases) | $47.19M | $47.85M | $48.54M | $49.14M | $49.94M | $50.82M | $51.72M | $52.54M |
| Common Stock | $2.86B | $2.83B | $2.41B | $2.36B | $2.33B | $2.30B | $2.28B | $1.70B |
| Retained Earnings | -$1.67B | -$1.55B | -$1.42B | -$1.29B | -$1.16B | -$1.05B | -$952.1M | -$871.5M |
| Accumulated Other Comp. Income | -$3.01M | -$1.25M | $1.86M | $2.19M | $1.62M | $2.00M | $963K | $2.04M |
| Total Stockholders' Equity | $1.19B | $1.28B | $992.1M | $1.07B | $1.17B | $1.25B | $1.32B | $833.0M |
| Total Equity | $1.19B | $1.28B | $992.1M | $1.07B | $1.17B | $1.25B | $1.32B | $833.0M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$465.3M | -$298.4M | -$214.5M | -$163.9M | -$107.6M | -$73.81M | -$50.42M | -$27.11M | -$9.16M | -$6.02M |
| Depreciation & Amortization | $3.90M | $2.80M | $1.10M | $983K | $922K | $948K | $887K | $471K | $128K | $92K |
| Stock-Based Compensation | $91.02M | $69.39M | $40.94M | $28.27M | $17.35M | $10.43M | $6.29M | $2.32M | $271K | $270K |
| Change in Receivables | -$592K | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$2.02M | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow | -$377.9M | -$230.2M | -$168.6M | -$115.2M | -$88.59M | -$62.03M | -$46.38M | -$19.46M | -$9.48M | -$5.47M |
| Capital Expenditure | -$5.76M | -$3.84M | -$4.69M | -$1.66M | -$436K | -$186K | -$492K | -$1.06M | -$304K | -$190K |
| Free Cash Flow | -$383.7M | -$234.0M | -$173.3M | -$116.9M | -$89.02M | -$62.21M | -$46.87M | -$20.52M | -$9.78M | -$5.66M |
| Purchases of Investments | -$1.00B | -$1.15B | -$527.9M | -$329.8M | -$125.4M | -$135.6M | -$108.1M | -$118.4M | -- | -- |
| Investing Cash Flow | $173.9M | -$574.8M | -$200.4M | -$174.0M | -$56.48M | $217K | $41.67M | -$119.5M | -$304K | -$190K |
| Common Stock Issued | $0 | $985.0M | $369.6M | $117.2M | $249.5M | $114.3M | -- | $106.5M | -- | -- |
| Financing Cash Flow | $40.61M | $1.01B | $391.2M | $122.0M | $252.7M | $114.6M | $67K | $170.2M | $11.82M | -$53K |
| Net Change in Cash | -$163.4M | $209.6M | $22.22M | -$167.2M | $107.6M | $52.76M | -$4.65M | $31.28M | $2.04M | -$5.71M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$120.9M | -$127.8M | -$122.8M | -$130.1M | -$115.6M | -$96.77M | -$80.59M | -$76.83M |
| Depreciation & Amortization | $1.07M | $1.16M | $994K | $1.01M | $959K | $925K | $788K | $770K |
| Stock-Based Compensation | $24.88M | $29.68M | $21.72M | $22.70M | $26.12M | $20.48M | $18.84M | $18.15M |
| Change in Receivables | -$6.27M | -$5.09M | -- | -- | $0 | $0 | -- | -- |
| Change in Inventory | -$358K | -$909K | -- | -- | $0 | $0 | -- | -- |
| Operating Cash Flow | -$94.19M | -$124.7M | -$92.90M | -$110.7M | -$85.85M | -$88.45M | -$66.87M | -$62.82M |
| Capital Expenditure | -$521K | -$820K | -$458K | -$863K | -$3.20M | -$1.24M | -$1.03M | -$528K |
| Free Cash Flow | -$94.71M | -$125.5M | -$93.36M | -$111.6M | -$89.05M | -$89.69M | -$67.90M | -$63.35M |
| Purchases of Investments | -$155.2M | -$554.4M | -$213.6M | -$216.7M | -$182.9M | -$391.2M | -$725.0M | -$130.0M |
| Investing Cash Flow | $26.29M | -$252.4M | $57.11M | $164.8M | $37.95M | -$85.96M | -$542.1M | $20.60M |
| Common Stock Issued | $0 | $380.5M | $0 | $0 | $0 | $0 | $543.5M | $48.14M |
| Financing Cash Flow | $8.93M | $389.9M | $26.04M | $3.08M | $7.05M | $4.44M | $556.2M | $57.33M |
| Net Change in Cash | -$58.98M | $12.81M | -- | $57.17M | -$40.84M | -$170.0M | -$52.72M | $15.11M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.0% | 100.0% | 100.0% | -- | -- | -- | -- | -- | -- | -- |
| Operating Margin | -6714.8% | -32613.5% | -5547.2% | -3544.1% | -9990.9% | -105567.6% | -4512.3% | -1182.5% | -446.3% | -1026.1% |
| Net Profit Margin | -6046.2% | -28720.7% | -5345.9% | -3460.4% | -9985.3% | -103960.6% | -4226.5% | -1116.8% | -447.8% | -1021.9% |
| Return on Equity (ROE) | -46.9% | -22.5% | -39.8% | -51.8% | -32.4% | -43.7% | -43.0% | -16.9% | -- | -- |
| Return on Assets (ROA) | -41.3% | -20.8% | -33.8% | -46.5% | -30.7% | -40.2% | -38.7% | -15.8% | -58.7% | -- |
| Current Ratio | 12.32x | 23.04x | 13.07x | 12.45x | 21.55x | 16.92x | 14.79x | 21.03x | 16.91x | -- |
| Quick Ratio | 12.30x | 23.04x | 12.71x | 12.06x | 20.86x | 16.29x | 14.20x | 20.68x | 15.82x | -- |
| Debt to Equity | 0.05x | 0.04x | 0.10x | 0.01x | 0.01x | 0.03x | 0.05x | -- | -- | -- |
| Revenue Growth (YoY) | +640.7% | -74.1% | -15.3% | +339.4% | +1418.3% | -94.0% | -50.9% | +18.7% | +247.2% | -- |
| Gross Profit Growth (YoY) | +537.2% | -74.1% | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +3408.9% | -73.9% | -65.4% | -93.9% | -95.2% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1302.5% | -3020.3% | -6714.8% | -31130.2% | -30392.2% | -49569.7% | -32613.5% | -29525.2% |
| Net Profit Margin | -1189.9% | -2747.2% | -6046.2% | -27563.3% | -26568.5% | -43191.1% | -28720.7% | -26747.8% |
| Return on Equity (ROE) | -42.1% | -38.8% | -46.9% | -39.5% | -31.6% | -26.2% | -22.5% | -33.4% |
| Return on Assets (ROA) | -37.9% | -35.4% | -41.3% | -35.4% | -28.7% | -24.1% | -20.8% | -29.6% |
| Current Ratio | 15.57x | 18.60x | 12.32x | 15.12x | 17.80x | 22.53x | 23.04x | 16.38x |
| Quick Ratio | 15.53x | 18.56x | 12.30x | 14.83x | 17.54x | 22.68x | 23.04x | 16.11x |
| Debt to Equity | 0.04x | 0.04x | 0.05x | 0.05x | 0.04x | 0.04x | 0.04x | 0.06x |
| Revenue Growth (YoY) | +2336.3% | +2873.4% | -- | -- | +158.4% | -43.6% | -- | -100.0% |
| Gross Profit Growth (YoY) | +2321.3% | +2818.0% | -- | -- | -- | -- | -- | -- |